Tracheal tissue engineering: Building on a strong foundation

Expert Review of Medical Devices

Volumn 10, Issue 1, 2013, Pages 33-35

  Hinderer, Svenja ^a,b,c   Schenke Layland, Katja ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

Author keywords

extracellular matrix; proteoglycans; stem cell seeded implant; tissue engineering; trachea

Indexed keywords

DECELLULARIZED; EXTRACELLULAR MATRICES; FOLLOW-UP STUDIES; MARROW-DERIVED STEM CELLS; PEDIATRIC PATIENTS; POLYDIOXANONE; PROTEOGLYCANS; REPLACEMENT STRATEGY; STRUCTURAL DISORDERS; TRACHEA;

RESPIRATORY SYSTEM; STEM CELLS; STENTS; TISSUE;

TISSUE ENGINEERING;

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; POLYDIOXANONE; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

AGENESIS; ALLOGRAFT; ANGIOGENESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; ENDOTRACHEAL STENT; FOLLOW UP; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LARYNX STENOSIS; MESENCHYMAL STEM CELL; STEM CELL; TISSUE ENGINEERING; TISSUE IMPLANT; TRACHEA; TRACHEA RECONSTRUCTION; TRACHEA STENOSIS;

EID: 84872002646     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.12.74     Document Type: Article

References (15)

1. Elliott MJ, De Coppi P, Speggiorin S et al. Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. Lancet 380(9846), 994-1000 (2012).
2. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; OPTN/SRTR 2010. Annual Data Report (2011).
3. Schenke-Layland K. From tissue engineering to regenerative medicine-the potential and the pitfalls. Adv. Drug. Deliv Rev. 63(4-5), 193-194 (2011).
4. Walles T. Tracheobronchial bio-engineering: Biotechnology fulfilling unmet medical needs. Adv. Drug Deliv. Rev. 63(4-5), 367-374 (2011).
5. Macchiarini P, Jungebluth P, Go T et al. Clinical transplantation of a tissue-engineered airway. Lancet 372(9655), 2023-2030 (2008).
6. Delaere P, Vranckx J, Verleden G, De Leyn P, Van Raemdonck D; Leuven Tracheal Transplant Group. Tracheal allotransplantation after withdrawal of immunosuppressive therapy. N. Engl. J. Med. 362(2), 138-145 (2010).
7. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 379(9819), 943-952 (2012).
8. Bayrak A, Tyralla M, Ladhoff J et al. Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents in vitro. Biomaterials 31(14), 3793-3803 (2010).
9. Baiguera S, Birchall MA, Macchiarini P. Tissue-engineered tracheal transplantation. Transplantation 89(5), 485-491 (2010).
10. Schenke-Layland K, Vasilevski O, Opitz F et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol. 143(3), 201-208 (2003). (Pubitemid 37297860)
11. Schenke-Layland K, Rofail F, Heydarkhan S et al. The use of threedimensional nanostructures to instruct cells to produce extracellular matrix for regenerative medicine strategies. Biomaterials 30(27), 4665-4675 (2009).
12. Petersen TH, Calle EA, Colehour MB, Niklason LE. Matrix composition and mechanics of decellularized lung scaffolds. Cells. Tissues. Organs 195(3), 222-231 (2012).
13. Hinderer S, Schesny M, Bayrak A et al. Engineering of fibrillar decorin matrices for a tissue-engineered trachea. Biomaterials 33(21), 5259-5266 (2012).
14. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J. Cell. Sci. 123(Pt 24), 4195-4200 (2010)
15. Schaefer L, Schaefer RM. Proteoglycans: From structural compounds to signaling molecules. Cell Tissue Res. 339(1), 237-246 (2010).